WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience New in Neuroscience from Oxford
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saura, J.
Right arrow Articles by Richards, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saura, J.
Right arrow Articles by Richards, J. G.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 12, 1977-1999, Copyright © 1992 by Society for Neuroscience


ARTICLE

Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19- 6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain

J Saura, R Kettler, M Da Prada and JG Richards
F. Hoffmann-La Roche Ltd., Pharma Division, Basel, Switzerland.

Monoamine oxidases A and B (MAO-A and MAO-B) oxidatively deaminate neurotransmitter and xenobiotic amines. Since the cellular localization of the isoenzymes in the CNS and peripheral organs determines to a large extent which substrate has access to which isoenzyme, knowledge of their tissue distribution and cellular localization is essential. Here we describe how reversible and selective inhibitors of MAO-A and MAO-B [Ro 41-1049 and Ro 19-6327 (lazabemide), respectively] can be used, as tritiated radioligands, to map the distribution and abundance of the enzymes in microscopic regions of the rat CNS and peripheral organs, and human brain by quantitative enzyme radioautography. The in vitro binding characteristics of both radiolabeled inhibitors revealed them to be selective, high-affinity ligands for the respective enzymes. KD and Bmax values for 3H-Ro 41-1049 in rat cerebral cortex were 10.7 nM and 7.38 pmol/mg protein, respectively, and for 3H-Ro 19-6327 were 18.4 nM and 3.45 pmol/mg protein, respectively. In accordance with their potencies as enzyme inhibitors, binding to MAO-A and MAO-B was competitively inhibited by clorgyline (IC50 = 1.4 nM) and L-deprenyl (selegiline; IC50 = 8.0 nM), respectively. The capacities of various rat and human tissues to bind the radioligands correlated extremely well with their corresponding enzyme activities. As revealed by the respective binding assays, the distribution and abundance of MAO-A and MAO-B in the tissues investigated differed markedly. MAO-A was most abundant in the locus coeruleus, paraventricular thalamus, bed nucleus of the stria terminalis, median habenular nucleus, ventromedial hypothalamus, raphe nuclei, solitary tract nucleus, inferior olives, interpeduncular nucleus, claustrum, and numerous peripheral tissues, including liver, vas deferens, heart, superior cervical ganglion, and exocrine and endocrine pancreas. In contrast, MAO-B was most abundant in the ependyma, circumventricular organs, olfactory nerve layer, periventricular hypothalamus, cingulum, hippocampal formation, raphe nuclei, paraventricular thalamus, mammillary nuclei, cerebellar Bergmann glia cells, liver, posterior pituitary, renal tubules, and endocrine pancreas. The cellular localization of the isoenzymes in both rat and human brain differs markedly and does not reflect the distribution of the presumed natural substrates, for example, absence of MAO-A in serotoninergic neurons. Indeed, the present evidence suggests that, whereas MAO-A is found in noradrenergic and adrenergic neurons, MAO-B occurs in astrocytes, serotoninergic neurons, as well as ventricular cells, including most circumventricular organs. The physiological roles of the enzymes are discussed in the light of these findings, some of which were unexpected.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Cancer Res.Home page
O. C. Neels, K. P. Koopmans, P. L. Jager, L. Vercauteren, A. van Waarde, J. Doorduin, H. Timmer-Bosscha, A. H. Brouwers, E. G.E. de Vries, R. A.J.O. Dierckx, et al.
Manipulation of [11C]-5-Hydroxytryptophan and 6-[18F]Fluoro-3,4-Dihydroxy-L-Phenylalanine Accumulation in Neuroendocrine Tumor Cells
Cancer Res., September 1, 2008; 68(17): 7183 - 7190.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
N. M.T. Freedman, E. Mishani, Y. Krausz, J. Weininger, H. Lester, E. Blaugrund, D. Ehrlich, and R. Chisin
In Vivo Measurement of Brain Monoamine Oxidase B Occupancy by Rasagiline, Using 11C-L-Deprenyl and PET
J. Nucl. Med., October 1, 2005; 46(10): 1618 - 1624.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Guillem, C. Vouillac, M. R. Azar, L. H. Parsons, G. F. Koob, M. Cador, and L. Stinus
Monoamine Oxidase Inhibition Dramatically Increases the Motivation to Self-Administer Nicotine in Rats
J. Neurosci., September 21, 2005; 25(38): 8593 - 8600.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y.-H. Huang, A. Ito, and R. Arai
Immunohistochemical Localization of Monoamine Oxidase Type B in Pancreatic Islets of the Rat
J. Histochem. Cytochem., September 1, 2005; 53(9): 1149 - 1158.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Valette, M. Bottlaender, F. Dolle, C. Coulon, M. Ottaviani, and A. Syrota
Acute Inhibition of Cardiac Monoamine Oxidase A after Tobacco Smoke Inhalation: Validation Study of [11C]Befloxatone in Rats Followed by a Positron Emission Tomography Application in Baboons
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 431 - 436.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Bottlaender, F. Dolle, I. Guenther, D. Roumenov, C. Fuseau, Y. Bramoulle, O. Curet, J. Jegham, J.-L. Pinquier, P. George, et al.
Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 467 - 473.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Remaury, R. Raddatz, C. Ordener, S. Savic, J. C. Shih, K. Chen, I. Seif, E. De Maeyer, S. M. Lanier, and A. Parini
Analysis of the Pharmacological and Molecular Heterogeneity of I2-Imidazoline-Binding Proteins using Monoamine Oxidase-Deficient Mouse Models
Mol. Pharmacol., November 1, 2000; 58(5): 1085 - 1090.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Inoue, K. Castagnoli, C. Van der Schyf, S. Mabic, K. Igarashi, and N. Castagnoli Jr
Species-Dependent Differences in Monoamine Oxidase A and B-Catalyzed Oxidation of Various C4 Substituted 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl Derivatives
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 856 - 864.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
G. Pineyro and P. Blier
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. B. Mercuri, M. Scarponi, A. Bonci, A. Siniscalchi, and G. Bernardi
Monoamine Oxidase Inhibition Causes a Long-Term Prolongation of the Dopamine-Induced Responses in Rat Midbrain Dopaminergic Cells
J. Neurosci., April 1, 1997; 17(7): 2267 - 2272.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-